Global decentralized studies will become a standard clinical trial design approach
The Pharma Data
MARCH 20, 2021
After a year of unprecedented disruption in the clinical research industry, 2021 is set to be another transformative year for sponsors and contract research organizations (CROs), according to John Reites, president of Thread, a technology and service provider focusing on decentralized clinical research. Source link: [link].
Let's personalize your content